论著

2005至2020年中国西南地区肝豆状核变性住院费用影响因素分析

展开
  • 1.四川大学华西医院神经内科,四川 成都 610041
    2.四川大学华西公共卫生学院 华西第四医院老年医学/神经内科,四川 成都 610041
    3.四川大学华西公共卫生学院,四川 成都 610041

收稿日期: 2021-06-20

  网络出版日期: 2022-07-25

基金资助

2017年上海交通大学医学院高峰学科-临床医学“研究型医师”队伍建设项目;2018年上海市”医苑新星”青年医学人才培养资助计划

Cost of hospitalization of patients with hepatolenticular degeneration in southwest of China: data analysis during 2005-2020

Expand
  • 1. Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China
    2. Department of Geriatric Medicine and Neurology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
    3. West China School of Public Health, Sichuan University, Chengdu 610041, China

Received date: 2021-06-20

  Online published: 2022-07-25

摘要

目的:研究肝豆状核变性患者住院费用的影响因素,为卫生政策的制定提供依据。方法:回顾性收集2005至2020年首次入住四川大学华西第四医院肝豆状核变性患者的病历数据,使用多重线性回归明确肝豆状核变性患者住院费用的影响因素;使用协方差分析控制混杂因素明确自变量对住院费用的影响。SPSS 20.0(IBM)用于数据分析。结果:纳入346例肝豆状核变性患者,使用多重线性回归分析后发现就诊年份、年龄、合并症数量、住院天数及并发肝硬化失代偿可导致住院费用变化。控制混杂因素后,发现随着合并症数量的增加及并发肝硬化失代偿可导致住院费用增加,同时2005—2006及2007—2008年患者的住院费用较其他年份减少。结论:肝豆状核变性是一种慢性病,其住院费用受就诊年份、年龄、合并症数量、住院天数及并发肝硬化失代偿影响,需通过不断完善就诊流程、建立临床路径、纳入门诊特殊病管理、减少合并症及延缓肝硬化失代偿发生的时间,从而减少肝豆状核变性的疾病负担。

本文引用格式

洪培伟, 丛雪, 徐严明 . 2005至2020年中国西南地区肝豆状核变性住院费用影响因素分析[J]. 内科理论与实践, 2021 , 16(05) : 315 -318 . DOI: 10.16138/j.1673-6087.2021.05.006

Abstract

Objective To analyze the hospitalization cost of the patients with hepatolenticular degeneration in southwest of China. Methods The data of hospitalization cost of the patients with hepatolenticular degeneration were acquired from electronic medical record system in West China Fourth Hospital from 2005 to 2020. Multiple linear regression analysis was utilized for analyzing the factors of hospitalization cost retrospectively, and covariance analysis was used for controlling the confounding factors. SPSS 20.0 (IBM) was applied for data analysis. Results A total of 346 patients with hepatolenticular degeneration were enrolled in our analysis. The year of admission, age, number of comorbidities, days of hospitalization, and complication of decompensated liver cirrhosis were the factors to influence the cost of hospitalization. After the confounding factors were adjusted, the hospitalization cost grew following the increase of comorbidity number, and complication of decompensated liver cirrhosis also led to the increase of hospitalization cost. The hospitalization cost of 2005-2006 and 2007-2008 were lower than those in the rest of years. Conclusions Hospitalization cost of the patients with hepatolenticular degeneration in southwest of China were influenced by number of comorbidities, complication of decompensated liver cirrhosis, and year to admit. It was important to reduce the occurrence of complication and decompensated liver cirrhosis, as to reduce the cost of hospitalization.

参考文献

[1] Chang IJ, Hahn SH. The genetics of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 19-34.
[2] Scheiber IF, Bruha R, Dušek P. Pathogenesis of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 43-55.
[3] Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features[J]. Handb Clin Neurol, 2017, 142: 101-119.
[4] Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 91-99.
[5] Dziezyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 157-169.
[6] Lo C, Bandmann O. Epidemiology and introduction to the clinical presentation of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 7-17.
[7] 胡文彬, 韩咏竹, 薛本春, 等. 安徽省含山县肝豆状核变性的流行病学研究[J]. 中华医学杂志, 2011, 91(13):894-897.
[8] Cheng N, Wang K, Hu W, et al. Wilson disease in the South Chinese Han population[J]. Can J Neurol Sci, 2014, 41(3): 363-367.
[9] 陈晨. 肝豆状核变性患者疾病经济负担的调查与分析[D]. 上海: 上海交通大学, 2015.
[10] European Association for Study of Liver. EASL clinical practice guidelines: Wilson’s disease[J]. J Hepatol, 2012, 56(3): 671-685.
[11] Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis[J]. Br Med J (Clin Res Ed), 1986, 292(6512): 13-15.
[12] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志, 2019, 27(11): 846-865.
[13] 韩小敬. 基于中医临床路径的肝豆状核变性卫生经济学评价[D]. 安徽: 安徽中医药大学, 2016.
文章导航

/